Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Blood Transfusion in Cerebral Palsy
NCT04098029Phase 2Unknown
- Sponsor
- Samara Regional Medical Center Dinasty
- Start
- Sep 2019
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of umbilical cord blood mononuclear cells in cerebral palsy (CP) (3 arms), sponsored by Samara Regional Medical Center Dinasty. Primary endpoints: Number of participants with non-serious and serious adverse events at 1 year, Gross Motor Function Classification System (GMFCS - ER) scale severity change at 12 months and 3 more. Status: unknown.
02
Drugs
umbilical cord blood mononuclear cells
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT04098029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04098029.